Research » Research at SMHS » Clinical & Translational Research » Clinical Research Contacts » Radwa Aly, MSc.

Radwa Aly, MSc.

Radwa Aly, MSc. Radwa Aly
Director of Clinical Research, Neurology/Neurosurgery/Ob Gyn/Newborn Services

Email: Email
Department: Neurology


  • B.S., Health Sciences George Mason University 2007
  • MSc, Clinical Translational Research, George Washington University, 2015
  • Principle Investigator Fellow, Massachusetts General Hospital 2018
  • PhD (Candidate) Translational Health Sciences George Washington University


Radwa Aly over 14 years of extensive experience in clinical research. She has spent 8 of those years working specifically in behavioral health and neurosciences, which is where her research interests are. She has obtained a Master of Science in Clinical and Translational Research in 2015 from the George Washington University School of Medicine and Health Sciences and is currently pursuing a PhD in Translational Health Sciences at the George Washington University School of Medicine and Health Sciences. Her doctoral research focus is in studying psychogenic non-epileptic seizures. Radwa was selected as a Principal investigator fellow and successfully completed her fellowship and PI Training at Mass General Hospital in 2018. She is currently a member of the GW chapter of the Golden Key National Honor Society.

Throughout her career, Radwa has successfully designed and implemented clinical research protocols with expert familiarity with FDA/IND/IDE requirements and submissions, collaborated in Designing and developing a Medical app currently being used just for research in studying catamenial epilepsy. Radwa has developed the infrastructure for a clinical research division within the Department of Neurology and Neurosurgery and currently oversees all research activity conducted in the Neurology/Neurosurgery clinical research unit which includes oversight of 20 + active clinical research studies covering epilepsy, myasthenia gravis, ALS, Parkinson’s disease, neuropathic pain, stroke and multiple sclerosis. She also has years of experience in leadership and regulatory management & oversight and proposal & budget development. She has contributed to the field of clinical research and behavioral sciences by co-authoring several abstracts and a book chapter on clinical trials in Myasthenia gravis.


Book Chapter:

Aly, R., Cutter, G., Kaminski, H. (2017). Clinical Trial Design for Myasthenia Gravis


Co-Author: Zilucoplan, a Subcutaneously Self-Administered Peptide Inhibitor of Complement Component 5 (C5), for the Treatment of Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. Zilucoplan in gMG Phase 2: Manuscript, JAMA Neurology


Aly, R., Chen, H., Becker, A., Koubeissi, M., Sheth. A. Barriers to epilepsy surgery utilization. American Epilepsy Society Annual Meeting Dec. 6, 2019

“Myasthenia Gravis Patient Registry: Significant Knowledge Gap in Understanding Disease Diagnosis and Treatment” Karim George Salame MD, Henry J. Kaminski MD, Gary Cutter PhD, Michelle Feese MPH, Radwa Aly Msc

Joseph A. Wong, Radwa Aly MSHS, Cynthia Phillip, Mohamad Koubeissi MD. “A Review of Patient Safety and Unique Considerations in the Epilepsy Monitoring Unit”

Guinevere Que, NP; Caroline Agha, MD; Radwa Aly MSHS, Uma Menon, MD. “Pregnancy and seizures: review of practice at George Washington University in the past five years”

Aly, R., V.Aroda, J.Maynard, S.Fernandez. The Relationship between Skin fluorescence and Chronic Glycemic Exposure in individuals with Type 1 Diabetes. Diabetes Care2011

Radwa Aly, Vanita Aroda MD1, Nathaniel Matter PhD2, Radwa Aly BS1, Baqiyyah Conway PhD3, John Maynard MS2, Trevor Orchard . "Noninvasive Measurement of Advanced Glycation End Products Correlates with Chronic Glycemic Exposure in Patients with Type 1 and Type 2 Diabetes"